A genetically engineered herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) deletion mutant has been constructed and used to investigate the role of this gene in pathogenesis. Inoculation of mice with the HSV TK deletion mutant resulted in the establishment of latent ganglionic infection as demonstrated by superinfection of explanted ganglia with wild-type (wt) virus but not by routine explant culture suggesting that the virus-encoded TK is not essential for the establishment of latent infection but may be necessary for either reactivation or virus replication following reactivation. In addition, Southern blot hybridization has been used to demonstrate in vivo complementation of this mutant by wt virus in both peripheral and central nervous system tissues of mice during acute infection and to show that such complementation can result in the establishment and reactivation of latent TK– infection.
BrownS. M.,
Subak-SharpeJ. H.,
WarrenK. G.,
WroblewskaA.,
KoprowskiH.1979; Detection of complementation of defective or uninducible (herpes simplex type 1) virus genomes latent in human ganglia. Proceedings of the National Academy of Sciences, U.S.A 76:2364–2368
DarbyG,
LarderB. A.,
InglisM. M.1986; Evidence that the ‘active centre’ of the herpes simplex virus thymidine kinase involves an interaction between three distinct regions of the polypeptide. Journal of General Virology 67:753–758
EfstathiouS.,
MinsonA. C.,
FieldH. J.,
AndersonJ. R.,
WildyP.1986; Detection of herpes simplex virus- specific DNA sequences in latently infected mice and in humans. Journal of Virology 57:446–455
FeinbergA. D.,
VogelsteinB.1983; A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Analytical Biochemistry 132:6–13
FieldH. J.,
DarbyG.1980; Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. Antimicrobial Agents and Chemotherap y 17:209–216
FieldH. J.,
LayE.1984; Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir. Antiuiral Research 4:43–52
FieldH. J.,
DarbyG.,
WildyP.1980; Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. Journal of General Virology 49:115–124
HillT. J.,
FieldH. J.,
BlythW. A.1975; Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. Journal of General Virology 28:341–353
JavierR. T.,
SedaratiF.,
StevensJ. G.1986; Two avirulent herpes viruses interact in the animal to generate virulent recombinants and a lethal infection. Science 234:746–748
KleinR. J.,
Friedman-KienA. E.,
De StefanoE.1981; Pathogenesis of experimental skin infections induced by drug resistant herpes simplex virus mutants. Infection and Immunity 34:693–701
KlempererH. G.,
HaynesG. R.,
SheddenW. I. H.,
WatsonD. H.1967; A virus-specific thymidine kinase in BHK-21 cells infected with herpes simplex virus. Virology 31:120–128
LarderB. A.,
DarbyG.1982; Properties of a novel thymidine kinase induced by an acyclovir-resistant herpes simplex virus type 1 mutant. Journal of Virology 42:649–658
LewisM. E.,
BrownS. M.,
WarrenK. G.,
Subak-SharpeJ. H.1984; Recovery of herpes simplex virus genetic information from human trigeminal ganglion cells following superinfection with herpes simplex virus type 2 temperature-sensitive mutants. Journal of General Virolog y 65:215–219
McdermottM. R.,
SmileyJ. R.,
BraisL. J.,
RudzrogaH. E.,
BienenstockJ.1984; Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. Journal of Virology 51:747–753
McgeochD. J.,
DalrympleM. A.,
DavisonA. J.,
DolanA.,
FrameM. C.,
McnabD.,
PerryL. J.,
ScottJ. E.,
TaylorP.1988; The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. Journal of General Virology 69:1531–1574
MclennanJ. L.,
DarbyG.1980; Herpes simplex virus latency: the cellular location of virus in dorsal root ganglia and the fate of the infected cell following virus activation. Journal of General Virology 51:233–243
MeignierB.,
LongneckerR.,
Mavromara-NazosP.,
SearsA. E.,
RoizmanB.1988; Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. Virology 162:251–254
PriceR. W.,
KhanA.1981; Resistance of peripheral autonomic neurons to in vivo productive infection by herpes simplex virus mutants deficient in thymidine kinase activity. Infection and Immunit y 34:571–580
ReadG. S.,
SharpJ. A.,
SummersW. C.1984; In vitro and in vivo transcription initiation sites on the TK- encoding BamH1 Q fragment of HSV-1 DNA. Virolog 138:368–372
RigbyP. W. J.,
DieckmannM.,
RhodesC.,
BergP.1977; Labelling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. Journal of Molecular Biology 113:237–251
SedaratiF.,
JavierR. T.,
StevensJ. G.1988; Pathogenesis of a lethal mixed infection in mice with two nonneuroinvasive herpes simplex virus strains. Journal of Virology 62:3037–3039
StowN. D.,
WilkieN. M.1976; An improved technique for obtaining enhanced infectivity with herpes simplex virus type 1 DNA. Journel of General Virology 33:447–458
TenserR. B.,
EdrisW. A.1987; Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation. Journal of Virology 61:2l71–2174
TenserR. B.,
ResselS.,
DunstanM. E.1981; Herpes simplex virus thymidine kinase expression in trigeminal ganglion infection: correlation of enzyme activity with ganglion virus titre and evidence of in vivo complementation. Virology 112:328–341
TenserR. B.,
IokesJ. C.,
ResselS. J.1985; Acute and latent infection by thymidine kinase mutants of herpes simplex virus type 2. Journal of Infectious Diseases 151:548–550